TD Cowen Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $20

Futu NewsOct 23 19:31 · Ratings

Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?

Zacks Oct 18 23:30

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

Zacks Oct 18 23:00

Teva Settles Patent Litigation With Amicus

Seeking AlphaOct 18 22:18

How Much Upside Is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%

Zacks Oct 18 21:05

BofA Securities Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Raises Target Price to $15

Futu NewsOct 18 20:31 · Ratings